2009 Form 990-PF - Bill & Melinda Gates Foundation

BILL & MELINDA GATES FOUNDATION 56-2618866
FORM 990PF, PART XV - GRANTS AND CONTRIBUTIONS PAID DURING THE YEAR
RELATIONSHIP TO SUBSTANTIAL CONTRIBUTOR
AND
ATTACHMENT 18 (CONT'D)
RECIPIENT NAME AND ADDRESS FOUNDATION STATUS OF RECIPIENT PURPOSE OF GRANT OR CONTRIBUTION AMOUNT
INTL CTR GENETIC ENG AND BIOTECH NONE DEEPAK GAUR, CHETAN CHITNIS AND VIRANDER
100,000.
ARUNA ASAF ALI MARG 110067 FOREIGN GOVERNMENT
NEW DELHI
DL
INDIA
CHAUHAN OF THE INTERNATIONAL CENTRE FOR
GENETIC ENGINEERING & BIOTECHNOLOGY IN INDIA
WILL ATTEMPT TO DEVELOP A BLOOD-STAGE MALARIA
VACCINE THAT USES A COMBINATION OF TWO
PROTEINS FOUND AMONG A WIDE DIVERSITY OF
MALARIA PARASITES. THEIR GOAL IS TO STIMULATE
ANTIBODIES THAT WOULD STOP PARASITE INFECTION
OF RED BLOOD CELLS BY BLOCKING MULTIPLE
PATHWAYS OF INVASION.
INTL CTR GENETIC ENG AND BIOTECH NONE RANJAN NANDA, K.V.S. RAO AND VIRANDER CHAUHAN OF
100,000.
ARUNA ASAF ALI MARG 110067 FOREIGN GOVERNMENT
NEW DELHI
DL
INDIA
THE INTERNATIONAL CENTRE FOR GENETIC ENGINEERING
& BIOTECHNOLOGY IN INDIA WILL GATHER BREATH
SAMPLES FROM TUBERCULOSIS PATIENTS AND USE GAS
CHROMATOGRAPHY-MASS SPECTROMETRY (GC-MS) TO
IDENTIFY AND TRACK UNIQUE MOLECULES SUCH AS
VOLATILE ORGANIC COMPOUNDS THAT CAN SERVE AS
BIOMARKERS TO DIAGNOSE TUBERCULOSIS. THE OVERALL
GOAL IS TO THEN CREATE A HANDHELD "ELECTRONIC
NOSE" TO DIAGNOSE THE DISEASE IN RESOURCE-POOR
SETTINGS.
INTL CTR GENETIC ENG AND BIOTECH NONE TO DEVELOP EFFECTIVE SAFETY AND REGULATORY
2,230,953.
PADRICIANO 99 - 34012 34012 FOREIGN GOVERNMENT
TRIESTE
ITALY
SYSTEMS IN THE FIELD OF MODERN BIOTECHNOLOGY
INTL DEVELOPMENT ENTERPRISES NONE TO DEVELOP SMALL-PLOT WATER TECHNOLOGIES,
3,563,853.
10403 WEST COLFAX AVENUE 509(A)(2)
SUITE 500
LAKEWOOD, CO 80215
FOR PUBLIC DISCLOSURE
126 OF 519
TECHNOLOGY MARKETS, AND CONNECT FARMERS TO
FRUIT AND VEGETABLE MARKETS IN ETHIOPIA,
ZAMBIA, NEPAL, AND MYANMAR
ATTACHMENT 18